SI
JAZZ icon

Stephens Inc’s Jazz Pharmaceuticals JAZZ Stock Holding History

Stephens Inc’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,093
Closed -$2M – 1304
2025
Q1 		$2M Buy
16,093
+10,916
+211% +$1.42M 0.03% 466
2024
Q4 		$638K Sell
5,177
-386
-7% -$45.5K 0.01% 743
2024
Q3 		$620K Buy
5,563
+771
+16% +$84.5K 0.01% 760
2024
Q2 		$511K Buy
4,792
+169
+4% +$18.6K 0.01% 786
2024
Q1 		$557K Buy
+4,623
New +$566K 0.01% 771
2019
Q4 		– Sell
-2,251
Closed -$288K – 1173
2019
Q3 		$288K Sell
2,251
-216
-9% -$29K 0.01% 924
2019
Q2 		$352K Sell
2,467
-22
-0.9% -$2.96K 0.01% 857
2019
Q1 		$356K Sell
2,489
-31
-1% -$4.04K 0.01% 857
2018
Q4 		$312K Sell
2,520
-136
-5% -$20.2K 0.01% 833
2018
Q3 		$447K Buy
+2,656
New +$457K 0.01% 806
2017
Q3 		– Sell
-2,802
Closed -$436K – 791
2017
Q2 		$436K Buy
2,802
+840
+43% +$128K 0.02% 601
2017
Q1 		$285K Buy
1,962
+100
+5% +$13K 0.01% 686
2016
Q4 		$203K Hold
1,862
– – 0.01% 715
2016
Q3 		$226K Buy
+1,862
New +$251K 0.01% 674
2016
Q1 		– Sell
-1,510
Closed -$212K – 775
2015
Q4 		$212K Hold
1,510
– – 0.01% 639
2015
Q3 		$201K Sell
1,510
-100
-6% -$17.2K 0.01% 649
2015
Q2 		$283K Buy
1,610
+100
+7% +$18K 0.01% 617
2015
Q1 		$261K Hold
1,510
– – 0.01% 650
2014
Q4 		$247K Sell
1,510
-60
-4% -$9.96K 0.01% 656
2014
Q3 		$252K Sell
1,570
-300
-16% -$46.1K 0.01% 649
2014
Q2 		$275K Buy
+1,870
New +$259K 0.01% 664

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Stephens Inc's JAZZ Position: Q2 2025 in Review

Stephens Inc sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 16,093 shares — an estimated $2M sold.

Stephens Inc first reported a position in JAZZ in Q2 2014 and held it in 21 quarters. The position peaked at $2M in Q1 2025. 502 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Stephens Inc reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Stephens Inc sold 16,093 Jazz Pharmaceuticals shares in Q2 2025, an estimated $2M.
  • Stephens Inc first reported a position in Jazz Pharmaceuticals in Q2 2014 and held it in 21 quarters.
  • Stephens Inc's Jazz Pharmaceuticals position peaked at $2M in Q1 2025.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Stephens Inc's 13F filing for Q2 2025, filed 29 Jul 2025.